Pacira BioSciences PCRX
NASDAQ PCRX
$25.05 -0.60 (-2.34%)
At close: Sep 30, 2026 · 4:00 PM EDT

Pacira BioSciences (PCRX) Revenue (2010 - 2026)

Updated

Pacira BioSciences (PCRX) reported Revenue of $192.4 million for Q2 2026, up 6.2% from $181.1 million a year earlier and up 8.5% from the prior quarter.

Analysis

Pacira BioSciences (PCRX) Revenue (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Pacira BioSciences' Revenue came in at $746.16 million, up 5.7% year-over-year; for FY2025, it was $726.41 million, up 3.6% from FY2024.

  • Revenue has increased for 15 consecutive years, with a five-year compound annual growth rate of 11.1% (FY2020 to FY2025).
  • By year, Revenue came in at $700.97 million in FY2024 (+3.9%), $674.98 million in FY2023 (+1.2%), $666.82 million in FY2022 (+23.1%) and $541.53 million in FY2021 (+26.0%).
  • Five-year quarterly Revenue spans a low of $127.72 million in Q3 2021 and a high of $196.87 million in Q4 2025.
  • Year over year, Revenue has now increased in each of the last 11 quarters, with growth averaging 4.0% over the last eight quarters.
  • The high point for year-over-year Revenue in five years was Q1 2022 (growth of 32.7%); the low point was Q3 2023 (a decline of 2.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $177.38 million (Q1 2026), $196.87 million (Q4 2025) and $179.52 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.31 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 16.99 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.38 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 7.80 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.33 Bn
10 Pacira BioSciences 997.55 Mn 59.58 Mn 148.24 Mn 192.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 192.40 Mn
Mar 31, 2026 177.38 Mn
Dec 31, 2025 196.87 Mn
Sep 30, 2025 179.52 Mn
Jun 30, 2025 181.10 Mn
Mar 31, 2025 168.92 Mn
Dec 31, 2024 187.25 Mn
Sep 30, 2024 168.57 Mn
Jun 30, 2024 178.02 Mn
Mar 31, 2024 167.12 Mn
Dec 31, 2023 181.24 Mn
Sep 30, 2023 163.93 Mn
Jun 30, 2023 169.47 Mn
Mar 31, 2023 160.34 Mn
Dec 31, 2022 171.96 Mn
Sep 30, 2022 167.47 Mn
Jun 30, 2022 169.41 Mn
Mar 31, 2022 157.99 Mn
Dec 31, 2021 159.19 Mn
Sep 30, 2021 127.72 Mn
API Access

Pacira BioSciences Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=PCRX&period=max&api_key=YOUR_API_KEY